Variant report
Variant | nsv511893 |
---|---|
Chromosome Location | chr6:66274779-66278085 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550640774 | chr6:66274820-66274821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201186582 | chr6:66274856-66274857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139800047 | chr6:66274867-66274868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369921536 | chr6:66274878-66274879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373390784 | chr6:66274908-66274909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs377449205 | chr6:66274914-66274915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540898007 | chr6:66274945-66274946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560786445 | chr6:66274946-66274947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529651737 | chr6:66275044-66275045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549535777 | chr6:66275046-66275047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536214076 | chr6:66275218-66275219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139734872 | chr6:66275230-66275231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370462391 | chr6:66275263-66275264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576624766 | chr6:66275294-66275295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143201047 | chr6:66275298-66275299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs151113462 | chr6:66275303-66275304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs371134985 | chr6:66275312-66275313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539068653 | chr6:66275317-66275318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140035799 | chr6:66275335-66275336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183028485 | chr6:66275353-66275354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535405395 | chr6:66275359-66275360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187643600 | chr6:66275394-66275395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534501219 | chr6:66275428-66275429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535314794 | chr6:66275436-66275437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs192371216 | chr6:66275463-66275464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs149852333 | chr6:66275514-66275515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557988659 | chr6:66275537-66275538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs55792659 | chr6:66275561-66275562 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs372948658 | chr6:66275620-66275621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183886603 | chr6:66275628-66275629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114647625 | chr6:66275630-66275631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542994096 | chr6:66275653-66275654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187751856 | chr6:66275658-66275659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377660493 | chr6:66275674-66275675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs377399242 | chr6:66275688-66275689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs141766602 | chr6:66275693-66275694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145420513 | chr6:66275719-66275720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147701030 | chr6:66275744-66275745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532891745 | chr6:66275761-66275762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546184658 | chr6:66275767-66275768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111330384 | chr6:66275768-66275769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12198506 | chr6:66275792-66275793 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs549008602 | chr6:66275799-66275800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71572536 | chr6:66275801-66275802 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs9453332 | chr6:66275802-66275803 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs371290915 | chr6:66275847-66275848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184624074 | chr6:66275862-66275863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188471740 | chr6:66275896-66275897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374339373 | chr6:66275970-66275971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79190515 | chr6:66275988-66275989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Retinitis pigmentosa | 21519034 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66268400-66277600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr6:66276000-66276600 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
3 | chr6:66276200-66276800 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
4 | chr6:66276200-66276800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:66276600-66277400 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr6:66276800-66277800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr6:66276800-66278600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr6:66277400-66278000 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr6:66277400-66279200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr6:66277400-66279200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr6:66277600-66277800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr6:66277600-66278000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr6:66277600-66278600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr6:66277600-66279600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr6:66277800-66278200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr6:66277800-66278200 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
17 | chr6:66278000-66278800 | Weak transcription | H1 Cell Line | embryonic stem cell |
18 | chr6:66278000-66279400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |